Skip to main content
. 2015 Dec 31;94(52):e2392. doi: 10.1097/MD.0000000000002392

FIGURE 2.

FIGURE 2

Kaplan–Meier survival curves for the nafamostat mesilate and no anticoagulant groups [(A) at 30 days; (B) at 90 days].